Your browser doesn't support javascript.
loading
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer.
Marks, Douglas K; Gartrell, Robyn D; El Asmar, Margueritta; Boboila, Shuobo; Hart, Thomas; Lu, Yan; Pan, Qingfei; Yu, Jiyang; Hibshoosh, Hanina; Guo, Hua; Andreopoulou, Eleni; Wiechmann, Lisa; Crew, Katherine; Sparano, Joseph; Hershman, Dawn; Connolly, Eileen; Saenger, Yvonne; Kalinsky, Kevin.
Affiliation
  • Marks DK; Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States.
  • Gartrell RD; Department of Pediatrics, Pediatric Hematology/Oncology and Medicine, Hematology/Oncology, Columbia University Irving Medical Center, New York, NY, United States.
  • El Asmar M; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Boboila S; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
  • Hart T; College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, United States.
  • Lu Y; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
  • Pan Q; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Yu J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Hibshoosh H; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
  • Guo H; Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Andreopoulou E; Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, United States.
  • Wiechmann L; Department of Surgery, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, United States.
  • Crew K; Department of Medicine, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, United States.
  • Sparano J; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
  • Hershman D; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, United States.
  • Connolly E; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States.
  • Saenger Y; Division of Radiation Oncology, Columbia University Irving Medical Center, New York, NY, United States.
  • Kalinsky K; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States.
Front Oncol ; 10: 968, 2020.
Article de En | MEDLINE | ID: mdl-32612958
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Front Oncol Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Risk_factors_studies Langue: En Journal: Front Oncol Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique